Our Lentiviral Cell Production service offers a cornerstone solution for the transfection-free, large-scale production of lentiviral vectors, pivotal for cell and gene therapy research. Available 24/7, this service facilitates the efficient generation of high-titer lentiviral vectors essential for various applications, including gene delivery, gene therapy, and cell reprogramming. By minimizing process complexity and reducing the overall cost, our lentiviral production capabilities support the advancement of therapeutic innovations from the laboratory to clinical application seamlessly.

Key features of our Lentiviral Cell Production service include:

• Efficient Scale-Up: Enabling large-scale production without compromising vector quality or functionality.
• Transfection-Free System: Utilizing advanced techniques to streamline the production process for greater efficiency and yield.
• Cost-Effective Production: Offering a streamlined approach to significantly lower the cost of goods in viral vector production.
• Broad Application Range: Supporting a wide array of research areas, from basic science to translational medicine.

Our expert team, equipped with cutting-edge technologies, ensures that your lentiviral vector production meets the highest standards of quality and safety. Whether for preclinical studies or clinical trial material production, our Lentiviral Cell Production service accelerates your path to discovery and therapeutic application, empowering your research with reliable, high-quality lentiviral vectors.